beta glucan glp-1 Effect of dietary supplementation with oat β-glucan for 3 months in subjects with type 2 diabetes: A randomized, double-blind, controlled clinical trial Supergut Unflavored GLP-1 Booster 15

Numerous analysts have said the GLP-1s are very likely to disrupt certain areas of the MedTech industry, while others say MedTech can live side-by-side with the weight-loss drugs.1 In fact, the impact of GLP-1s is likely to be more nuanced than the blunt conclusions drawn by market watchers, with some companies and segments affected more than others

Buford debunks some of the most common myths associated with GLP-1 agonists for weight loss

Traveling with injectable semaglutide requires understanding TSA liquid rules, temperature control, and prescription documentation

And explains why many plans are dropping coverage for an effective (and cost-effective) class of drugs